News

As part of the deal, Viking will provide financial support and access to its proprietary library of thyroid beta agonists for AMC scientists to evaluate in preclinical models

The company said that Pazeo solution is dosed one drop daily, and was approved with efficacy data at 24 hours, post dose. The approval was based on data

Also known as anti-PDL1 and RG7446, MPDL3280A is an investigational monoclonal antibody, designed to interfere with a protein called PD-L1. The approval was granted to treat these patients

Glyxambi is approved as an adjunct to diet and exercise to improve glycemic control in these adults when both empagliflozin and linagliptin are appropriate treatments. The drug is

Factor VIIa-CTP is a new, long-acting recombinant Factor VIIa using the company’s proprietary technology to extend its circulatory half-life without the use of polymers, encapsulation techniques or nanoparticles.

As of this date, Amherst has not paid or entered into an agreement to pay the FDA the amount owed. Under the terms of our agreement with Amherst,

"Through the acquisition of Aquarius and its novel lipid-based, targeted drug delivery platform, Matinas BioPharma significantly expands its technological portfolio with several product candidates in the field of

The therapeutic focus will be on acute bleeding in the lungs (Diffuse Alveolar Hemorrhage) and if successful Serendex Pharmaceuticals might be able to offer breakthrough therapy in this

"Executing on VTI-208 has been our primary focus over the last two years at about 50 leading hospitals in the U.S., Europe and Australia," said Terry Winters, Ph.D.,